A multicenter study by Wang, published in the BMJ Journal and recently presented at the 16th World Stroke Congress in October 2024, showed that combining two drugs improved the chances of a function recovery from stroke by 24%.
The TASTE-2 trial shows that combining edaravone (an antioxidant) and dexborneol (a type of anti inflammatory) together offer the potential of improved stroke recovery.
This highlights the importance of new treatments to improve recovery and improve the quality of life for stroke survivors.
Comentarios